| Heart disease and stroke statistics—2017 update: a report from the American Heart Association EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ... circulation 135 (10), e146-e603, 2017 | 48098* | 2017 |
| European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other … European journal of preventive cardiology 19 (4), 585-667, 2012 | 7227 | 2012 |
| Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetes care 41 (12), 2669-2701, 2018 | 4199 | 2018 |
| Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future SE Kahn, ME Cooper, S Del Prato The Lancet 383 (9922), 1068-1083, 2014 | 2168 | 2014 |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1371 | 2018 |
| Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations F Rubino, DM Nathan, RH Eckel, PR Schauer, KGMM Alberti, PZ Zimmet, ... Diabetes care 39 (6), 861-877, 2016 | 1305 | 2016 |
| How do we define cure of diabetes? JB Buse, S Caprio, WT Cefalu, A Ceriello, S Del Prato, SE Inzucchi, ... Diabetes care 32 (11), 2133-2135, 2009 | 1199 | 2009 |
| Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes V Lyssenko, R Lupi, P Marchetti, S Del Guerra, M Orho-Melander, ... The Journal of clinical investigation 117 (8), 2155-2163, 2007 | 1089 | 2007 |
| Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance LC Groop, RC Bonadonna, S DelPrato, K Ratheiser, K Zyck, E Ferrannini, ... The Journal of clinical investigation 84 (1), 205-213, 1989 | 1070 | 1989 |
| COVID-19 in people with diabetes: understanding the reasons for worse outcomes M Apicella, MC Campopiano, M Mantuano, L Mazoni, A Coppelli, ... The lancet Diabetes & endocrinology 8 (9), 782-792, 2020 | 996 | 2020 |
| New-onset diabetes in Covid-19 F Rubino, SA Amiel, P Zimmet, G Alberti, S Bornstein, RH Eckel, ... New England Journal of Medicine 383 (8), 789-790, 2020 | 883 | 2020 |
| Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent … R Lupi, F Dotta, L Marselli, S Del Guerra, M Masini, C Santangelo, ... Diabetes 51 (5), 1437-1442, 2002 | 858 | 2002 |
| Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, VR Aroda, BS Collins, RA Gabbay, J Green, NM Maruthur, ... Diabetes care 45 (11), 2753-2786, 2022 | 732 | 2022 |
| Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind … MA Nauck, S Del Prato, JJ Meier, S Durán-García, K Rohwedder, M Elze, ... Diabetes care 34 (9), 2015-2022, 2011 | 728 | 2011 |
| Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients F Dotta, S Censini, AGS van Halteren, L Marselli, M Masini, S Dionisi, ... Proceedings of the National Academy of Sciences 104 (12), 5115-5120, 2007 | 721 | 2007 |
| Management of type 2 diabetes: new and future developments in treatment AA Tahrani, CJ Bailey, S Del Prato, AH Barnett The Lancet 378 (9786), 182-197, 2011 | 691 | 2011 |
| Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ... The lancet Diabetes & endocrinology 9 (10), 653-662, 2021 | 629 | 2021 |
| The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia RA DeFronzo, JA Davidson, S Del Prato Diabetes, Obesity and Metabolism 14 (1), 5-14, 2012 | 618 | 2012 |
| Intermediate metabolism in normal pregnancy and in gestational diabetes G Di Cianni, R Miccoli, L Volpe, C Lencioni, S Del Prato Diabetes/metabolism research and reviews 19 (4), 259-270, 2003 | 602 | 2003 |
| Functional and molecular defects of pancreatic islets in human type 2 diabetes S Del Guerra, R Lupi, L Marselli, M Masini, M Bugliani, S Sbrana, S Torri, ... Diabetes 54 (3), 727-735, 2005 | 599 | 2005 |
